RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)

RxSight (RXST) has 6 years of Total Non-Current Liabilities data on file, last reported at $32.9 million in Q4 2025.

• For the quarter ending Q4 2025, Total Non-Current Liabilities fell 7.56% year-over-year to $32.9 million; the trailing twelve-month figure through Dec 2025 stood at $32.9 million (down 7.56% YoY), and the FY2025 full-year result was $32.9 million, down 7.56% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $32.9 million, up from $32.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $60.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2024.
• The 5-year median for Total Non-Current Liabilities is $33.2 million (2024), against an average of $36.6 million.
• The widest annual swing landed in 2023, when Total Non-Current Liabilities tumbled 63.3%; it then surged 75.34% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $54.5 million in 2021, then increased by 10.62% to $60.3 million in 2022, then sank by 63.3% to $22.1 million in 2023, then jumped by 61.1% to $35.6 million in 2024, then declined by 7.56% to $32.9 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $32.9 million (Q4 2025), $32.6 million (Q3 2025), and $31.0 million (Q2 2025), per Business Quant data.

Peer Comparison